Correlation Between Ambu AS and Zealand Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ambu AS and Zealand Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ambu AS and Zealand Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ambu AS and Zealand Pharma AS, you can compare the effects of market volatilities on Ambu AS and Zealand Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ambu AS with a short position of Zealand Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ambu AS and Zealand Pharma.

Diversification Opportunities for Ambu AS and Zealand Pharma

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Ambu and Zealand is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Ambu AS and Zealand Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zealand Pharma AS and Ambu AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ambu AS are associated (or correlated) with Zealand Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zealand Pharma AS has no effect on the direction of Ambu AS i.e., Ambu AS and Zealand Pharma go up and down completely randomly.

Pair Corralation between Ambu AS and Zealand Pharma

Assuming the 90 days trading horizon Ambu AS is expected to under-perform the Zealand Pharma. In addition to that, Ambu AS is 1.03 times more volatile than Zealand Pharma AS. It trades about -0.11 of its total potential returns per unit of risk. Zealand Pharma AS is currently generating about -0.07 per unit of volatility. If you would invest  86,050  in Zealand Pharma AS on August 28, 2024 and sell it today you would lose (12,200) from holding Zealand Pharma AS or give up 14.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Ambu AS  vs.  Zealand Pharma AS

 Performance 
       Timeline  
Ambu AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ambu AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Zealand Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Ambu AS and Zealand Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ambu AS and Zealand Pharma

The main advantage of trading using opposite Ambu AS and Zealand Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ambu AS position performs unexpectedly, Zealand Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zealand Pharma will offset losses from the drop in Zealand Pharma's long position.
The idea behind Ambu AS and Zealand Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules